MichaelHVeederMD

Oncology • Peoria, IL

Hematologic Oncology

Physician

Join to view full profile

Dr. Veeder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Veeder's full profile

Already have an account?

Office
8940 N Wood Sage Rd
Peoria, IL 61615
Phone+1 309-243-3000

Fax+1 309-243-3050
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1981 - 1982
George Washington UniversityResidency, Internal Medicine, 1976 - 1978
MedStar Health/Georgetown University HospitalInternship, Internal Medicine, 1975 - 1976
Yale School of MedicineClass of 1975

Certifications & Licensure

IL State Medical License 1982 - 2026
IA State Medical License 1992 - 2008
NC State Medical License 1978 - 1982
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Publications & Presentations

PubMed

58 citations
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors
David S. Hong, Drew W. Rasco, Michael H. Veeder, Jason J. Luke, Jason C. Chandler, Ani Sarkis Balmanoukian, Thomas J. George, Pamela N. Munster, Jordan Berlin, Martin ...> ;Oncology. 2019 Jan 1
57 citations
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central C...
David J. Inwards, Paul A. S. Fishkin, David W. Hillman, David W. Brown, Stephen M. Ansell, Paul J. Kurtin, Rafael Fonseca, Roscoe F. Morton, Michael H. Veeder, Thomas ...> ;Cancer. 2008 Jul 1
13 citations
Hematologic and cytogenetic spontaneous remission in acute monocytic leukemia (FAB M5b) with trisomy 8.
Antoine Daccache, Tinoy Kizhakekuttu, James Siebert, Michael H. Veeder> ;Journal of Clinical Oncology. 2007 Jan 20
15 citations
A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932
Edith A. Perez, Vera J. Suman, Tom R. Fitch, James A. Mailliard, James N. Ingle, John T. Cole, Michael H. Veeder, Patrick J. Flynn, Daniel J. Walsh, Ferdinand Addo> ;Oncology. 2005 Sep 1
121 citations
Phase III Study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction Chemotherapy Followed by Either Standard Thoracic Radiotherapy or Hyperfractionated Ac...
Chandra P. Belani, Wei Wang, David H. Johnson, Henry N. Wagner, Joan H. Schiller, Michael Veeder, Minesh P. Mehta> ;Journal of Clinical Oncology. 2005 Jun 1
28 citations
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
Patrick A. Burch, James A. Mailliard, David W. Hillman, Edith A. Perez, James E. Krook, Kendrith M. Rowland, Michael H. Veeder, Michael W. Cannon, James N. Ingle> ;American Journal of Clinical Oncology. 2005 Apr 1
57 citations
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
Edward T. Creagan, Vera J. Suman, Robert J. Dalton, Henry C. Pitot, Harry J. Long, Michael H. Veeder, Allen M. Vukov, Kendrith M. Rowland, James E. Krook, John C. Mich...> ;Journal of Clinical Oncology. 1999 Jun 1
57 citations
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma
James N. Ingle, Vera J. Suman, Carl G. Kardinal, James E. Krook, James A. Mailliard, Michael H. Veeder, Charles L. Loprinzi, Robert J. Dalton, Lynn C. Hartmann, Cheryl...> ;Cancer. 1999 Mar 15
3 citations
A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma
Edward T. Creagan, Michael H. Veeder, Vera J. Suman, Patrick A. Burch, William J. Maples, Paul L. Schaefer, Delano M. Pfeifle, Robert J. Dalton, Alan K. Hatfield, Mich...> ;American Journal of Clinical Oncology. 1998 Oct 1
275 citations
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
Debra L. Barton, Charles L. Loprinzi, Susan K. Quella, Jeff A. Sloan, Michael H. Veeder, James R. Egner, Pat Fidler, Philip J. Stella, Debra K. Swan, Nancy L. Vaught, ...> ;Journal of Clinical Oncology. 1998 Feb 1
2 citations
Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer.
James N. Ingle, Carl G. Kardinal, Vera J. Suman, Michael H. Veeder, Paul L. Schaefer, Ronnie J. Kirschling, James A. Mailliard> ;Breast Cancer Research and Treatment. 1997 May 1
84 citations
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
John E. Olson, Donna Neuberg, Kishan J. Pandya, Melvyn P. Richter, Lawrence J. Solin, Kennedy W. Gilchrist, Douglass C. Tormey, Michael H. Veeder, Geoffrey Falkson> ;Cancer. 1997 Mar 15
10 citations
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor
Terrence L. Cascino, Michael H. Veeder, Jan C. Buckner, Judith R. O'Fallon, Martin Wiesenfeld, Ralph Levitt, Richard M. Goldberg, Steven A. Kuross, Roscoe F. Morton, B...> ;Journal of Neuro-Oncology. 1996 Dec 1
19 citations
A Prospective Study of Pulmonary Function in Patients Receiving Mitomycin
Mario Castro, Michael H. Veeder, James A. Mailliard, Henry D. Tazelaar, James R. Jett> ;Chest. 1996 Apr 1
36 citations
A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma
Richard M. Goldberg, Charles G. Moertel, Harry S. Wieand, James E. Krook, Allan J. Schutt, Michael H. Veeder, James A. Mailliard, Robert J. Dalton> ;Cancer. 1995 Sep 15
10 citations
Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Endometrial Carcinoma
Harry J. Long, Robert M. Langdon, Stephen S. Cha, Michael H. Veeder, Delano M. Pfeifle, James E. Krook, Larry P. Ebbert, Loren K. Tschetter, Steven G. Roshon> ;Gynecologic Oncology. 1995 Aug 1
688 citations
Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report
Charles G. Moertel, Thomas R. Fleming, Daniel G. Haller, John A. Laurie, Catherine M. Tangen, James S. Ungerleider, William A. Emerson, Douglass C. Tormey, John H. Gli...> ;Annals of Internal Medicine. 1995 Mar 1
11 citations
Inhibition of 5 ‐ fluorouracil‐induced ocular irritation by ocular ice packs
Charles L. Loprinzi, Donald B. Wender, Michael H. Veeder, Judith R. O'Fallon, L R N Nancy Vaught, R N Ann Marie Dose, Chirantan Ghosh, R N Joan Bartel, John M. Leitch> ;Cancer. 1994 Aug 1
19 citations
Randomized trial of cyclophosphamide, methotrexate, and 5‐fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer
James N. Ingle, John F. Foley, James A. Mailliard, James E. Krook, Lynn C. Hartmann, Sin-Ho Jung, Michael H. Veeder, Dean H. Gesme, Alan K. Hatfield, Richard M. Goldberg> ;Cancer. 1994 May 1
10 citations
Phase II trial of edatrexate in small cell lung cancer
Martin Wiesenfeld, James R. Jett, John Q. Su, Theodore A. Braich, Carl G. Kardinal, James A. Mailliard, Michael H. Veeder, Roscoe F. Morton, John C. Michalak> ;Cancer. 1994 Feb 15
48 citations
Sequencing and schedule effects of cisplatin plus etoposide in small- cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial
Andrew Maksymiuk, James R. Jett, John D. Earle, John Q. Su, F A Diegert, James A. Mailliard, Carl G. Kardinal, James E. Krook, Michael H. Veeder, Martin Wiesenfeld> ;Journal of Clinical Oncology. 1994 Jan 1
224 citations
Transdermal Clonidine for Ameliorating Tamoxifen-Induced Hot Flashes
Richard M. Goldberg, Charles L. Loprinzi, Judith R. O'Fallon, Michael H. Veeder, Angela W. Miser, James A. Mailliard, John C. Michalak, Ann Marie Dose, Kendrith M. Row...> ;Journal of Clinical Oncology. 1994 Jan 1
26 citations
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma
Michael H. Veeder, James R. Jett, John Q. Su, James A. Mailliard, John F. Foley, Robert J. Dalton, Paul S. Etzell, Robert F. Marschke, Carl G. Kardinal, Andrew W. Maks...> ;Cancer. 1992 Nov 1
48 citations
A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma.
Edward T. Creagan, D I Twito, S L Johansson, Daniel J. Schaid, P S Johnson, M A Flaum, T R Buroker, L. H. Geeraerts, Michael H. Veeder, D H Gesme> ;Journal of Clinical Oncology. 1991 Dec 1
190 citations
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy.
D J Mahood, Ann Marie Dose, Charles L. Loprinzi, Michael H. Veeder, Laurie M. Athmann, Terry M. Therneau, J M Sorensen, D K Gainey, James A. Mailliard, N L Gusa> ;Journal of Clinical Oncology. 1991 Mar 1
Join now to see all